Cosmos Health Inc (COSM)

$0.53 +0.01 (1.15%)
Market Cap 18.16M
Revenue (ttm) 54.43M
Net Income (ttm) -16.18M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -29.73%
Debt to Equity Ratio 0.41
Volume 149,500
Avg Vol 565,992
Day's Range N/A - N/A
Shares Out 34.92M
Stochastic %K 65%
Beta 5.34
Analysts Strong Buy
Price Target $3.00

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, Croatia, Bulgaria, the United Arab Emirates, the United Kingdom, and Cyprus. The company offers prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It also provides ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogrel), LIPICHOL (Atorvas...

Industry: Medical Distribution
Sector: Healthcare
Phone: 312 536 3102
Address:
141 West Jackson Boulevard, Suite 4236, Chicago, United States
InfernoInv
InfernoInv Dec. 25 at 8:49 AM
$COSM Upside depends on translating ambition into measurable cadence, where each milestone now functions as a credibility checkpoint. Proof points carry more weight than guidance alone.
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 11:57 PM
$COSM This crooked CEO = dilution up the ass!
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 8:06 PM
$COSM With one trade this just shit the bed almost 6%. You people are in for a rude awakening Friday and next week when most baggies will be selling for next year's tax write off. I would be shocked if this isn't in the .30's by end of next week.
0 · Reply
BearTrapperA57
BearTrapperA57 Dec. 24 at 7:23 PM
$COSM he can buy all the shares he wants but he dilutes to do so
0 · Reply
Yatoxksy
Yatoxksy Dec. 24 at 7:17 PM
https://feeds.issuerdirect.com/news-release.html?newsid=8437669776005189&symbol=COSM Another paid promotional release focused on platform narrative and execution — while omitting material governance facts. Since 2022, shareholders have experienced severe dilution, with the share count expanding materially alongside executive compensation practices. Those facts are not addressed here. Claims and outcomes reconcile over time. Filings, facts, and results ultimately prevail. $COSM #ShareholderRights #Accountability #BoardAccountability
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 5:57 PM
$COSM Never getting your bags lifted.
0 · Reply
JohnTrack
JohnTrack Dec. 24 at 5:41 PM
$COSM still lurking, still watching...
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 5:07 PM
$COSM This crooked CEO has a Christmas gift for all you retail baggies/bulls ... and he doesn't believe in lube!
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 4:45 PM
$COSM This is ugly folks! The SEC or DOJ needs to shut this stock down and start arresting management ... beginning with the CEO!
0 · Reply
JohnTrack
JohnTrack Dec. 24 at 3:48 PM
$COSM news published some minutes ago https://www.rapidticker.com/news/cosm-cosmos-health-is-building-a-9d430b
0 · Reply
Latest News on COSM
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

Dec 24, 2025, 9:00 AM EST - 20 hours ago

Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy

Cosmos Health is Forcing the Market to Reframe the Conversation

Dec 19, 2025, 9:00 AM EST - 5 days ago

Cosmos Health is Forcing the Market to Reframe the Conversation

Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets

Dec 3, 2025, 12:20 PM EST - 21 days ago

Cosmos Health Launches Strategic Partnership With Prime Ledger to Transform $300M Treasury and Tokenize IP Assets

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

Dec 2, 2025, 12:15 PM EST - 22 days ago

Cosmos Health CEO Greg Siokas Adds 3,398,055 Shares Year-to-Date 2025 Following Continued November Purchases

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

Nov 17, 2025, 9:15 AM EST - 5 weeks ago

Cosmos Health Reports Record Q3 2025 Results with All-Time High Revenue, Gross Profit and Gross Margin; Revenue Up 38% to $17.1M, Gross Profit Up 116% to $2.6M, Adjusted EBITDA Up 74%, Cash Position Up to $4.63M from $0.66M

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

Oct 31, 2025, 10:45 AM EDT - 7 weeks ago

Cosmos Health Enters New Nanotechnology R&D Program to Develop Next-Generation Nutraceutical Formulas with Enhanced Phytochemical Efficacy

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

Oct 21, 2025, 12:10 PM EDT - 2 months ago

Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

Oct 13, 2025, 2:05 PM EDT - 2 months ago

Cosmos Health Purchases an Additional $300,000 in Ethereum Under Its $300 Million Digital Assets Facility; Total Investment Reaches $1.8 Million

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Oct 10, 2025, 8:00 AM EDT - 2 months ago

Cosmos Health Purchases an Additional $500,000 in Ethereum Pursuant to its $300 Million Digital Assets Facility

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

Oct 3, 2025, 3:56 PM EDT - 2 months ago

Cosmos Health Expands Sky Premium Life Into $1Bn+ Kuwait Market; Signs Exclusive Distribution Agreement With Diyar United and Secures Initial Purchase Order of Over 65,000 Units

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Sep 29, 2025, 8:00 AM EDT - 3 months ago

Cosmos Health CEO Issues Letter to Shareholders: Building a Global Healthcare Powerhouse with $300M Digital Financing Facility, U.S. Manufacturing Expansion, and AI Innovation

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Sep 25, 2025, 8:00 AM EDT - 3 months ago

Cosmos Health Expands Order Book with Contract Manufacturing Agreement with Medical Pharmaquality S.A. for 3 Million MYCOFAGYL® Pessaries Annually

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Sep 22, 2025, 8:00 AM EDT - 3 months ago

Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Sep 11, 2025, 8:00 AM EDT - 3 months ago

Cosmos Health Expands Presence in the $7 Billion GCC Nutraceuticals Market, Signs Distribution Agreement with Scientific Pharmacy for Sky Premium Life in Oman, Including Initial Purchase Order of 42,000 Units

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Aug 18, 2025, 12:45 PM EDT - 4 months ago

Cosmos Health Reports Q2 2025 Results; Continues Strong Growth with 11.7% Revenue Increase; On Track to Meet Profitability Targets with Gross Profit Up 53% to $3.21M in H1 2025

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Aug 12, 2025, 9:50 AM EDT - 4 months ago

Cosmos Health Makes Initial $1M Ethereum Purchase Under Digital Asset Treasury Strategy

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Aug 6, 2025, 9:20 AM EDT - 5 months ago

Cosmos Health Secures up to $300 Million Financing Facility to Launch Ethereum Treasury Strategy

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

Jun 24, 2025, 10:55 AM EDT - 6 months ago

Cosmos Health Enters U.S. Market with Strategic Made-in-America Manufacturing, Mitigating Tariff Risks; Executes Agreement with New Jersey-Based DolCas Biotech

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 2:30 PM EDT - 7 months ago

RETRANSMISSION – Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

May 15, 2025, 9:30 AM EDT - 7 months ago

Cosmos Health Reports Q1 2025 Results: Adjusted Profitability Achieved as Gross Profit Rises 54% to $2.05M; Operating Cash Burn Down 95%, or $3.2M, to $0.19M; Approaching Cash Flow Breakeven

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

May 7, 2025, 2:30 PM EDT - 8 months ago

Cosmos Health Secures Follow-Up Order from Pharmalink for 80,000 Sky Premium Life Units in the UAE; Initial 130,000-unit Order Sold Out, Advancing 5-Year Goal of Over 3 Million Units

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

May 6, 2025, 1:40 PM EDT - 8 months ago

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Apr 30, 2025, 12:50 PM EDT - 8 months ago

Cosmos Health CEO Greg Siokas Acquires 1,466,764 Shares Valued at $526,000 Over the Past Week; 2,777,469 Shares Acquired Over the Past Five Months for $1,325,000

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Apr 16, 2025, 12:45 PM EDT - 9 months ago

Cosmos Health Reports Full-Year 2024 Results: Revenue Increases 2% to $54.43 Million While Operating Expenses Decline 24.2% to $19.86 Million

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Apr 9, 2025, 1:40 PM EDT - 9 months ago

Cosmos Health Further Expands Facility Upgrades Program at Cana Laboratories and Signs 5-Year Contract Manufacturing Agreement with Pharmex for 1.5 Million Bottles of the Antiseptic Drug AMBITASOL 1L

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Apr 8, 2025, 10:45 AM EDT - 9 months ago

Cosmos Health Launches Sky Premium Life in Albania through Partnership with Pharma Cell; Secures Initial $300,000 Order

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

Feb 26, 2025, 11:30 AM EST - 10 months ago

Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Feb 18, 2025, 8:30 AM EST - 11 months ago

Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Feb 11, 2025, 10:15 AM EST - 11 months ago

Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Feb 10, 2025, 1:30 PM EST - 11 months ago

Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Feb 10, 2025, 9:45 AM EST - 11 months ago

Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Feb 7, 2025, 10:00 AM EST - 11 months ago

Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Feb 6, 2025, 3:50 PM EST - 11 months ago

Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Feb 5, 2025, 11:05 AM EST - 11 months ago

Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Jan 28, 2025, 11:00 AM EST - 11 months ago

Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Jan 27, 2025, 3:50 PM EST - 11 months ago

Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

Jan 23, 2025, 3:35 PM EST - 11 months ago

Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait

VRAX

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

Jan 22, 2025, 8:00 AM EST - 1 year ago

Cosmos Health Secures Two WIPO-Patented Anticancer Drugs for Prostate, Ovarian, and Colorectal Cancers, Valued at Over $24.5 Million

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

Jan 21, 2025, 3:00 PM EST - 1 year ago

Cosmos Health CEO Greg Siokas Acquires a Total of 647,809 Shares Valued at $425,000 Over the Past 32 Days

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

Jan 13, 2025, 9:20 AM EST - 1 year ago

Cosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC Countries

VRAX

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

Dec 26, 2024, 1:30 PM EST - 1 year ago

Cosmos Health Strengthens R&D Leadership and Innovation with the Appointment of Professor Dimitrios Trafalis, MD, as Head of Oncology

Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

Dec 23, 2024, 9:25 AM EST - 1 year ago

Cosmos Health CEO Greg Siokas and CFO George Terzis Collectively Increase Stake by 343,000 Shares Valued at $200,000

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Nov 18, 2024, 8:00 AM EST - 1 year ago

Cosmos Health Integrates Bitcoin and Ethereum as Treasury Reserve Assets

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

Nov 15, 2024, 10:20 AM EST - 1 year ago

Cosmos Health Reports Q3 2024 Results: Resilient Revenue and Gross Profit Amid 18.6% Expense Reduction; Stockholders' Equity Up 8.8% to $35M

Cosmos Health Issues Letter to Shareholders

Nov 12, 2024, 12:00 PM EST - 1 year ago

Cosmos Health Issues Letter to Shareholders

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

Nov 1, 2024, 12:30 PM EDT - 1 year ago

Cosmos Health's Subsidiary CosmoFarm Achieves Record Revenue, Up 8.62% to $43 Million YTD 2024, with Gross Profit Rising 21%

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

Sep 25, 2024, 9:25 AM EDT - 1 year ago

Cosmos Health Reports Strong 160% Increase in 2024 YTD Sales on Amazon UK for Its Proprietary Brands

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Sep 23, 2024, 12:55 PM EDT - 1 year ago

Cosmos Health Receives Initial Orders Exceeding $500,000 for C-Scrub in the UK; Future Orders Booked at Accelerated Pace with Strong Profitability Anticipated Due to High Profit Margins

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Sep 23, 2024, 9:00 AM EDT - 1 year ago

Cosmos Health Expands Global Presence into India, a Market with Over 1.4Bn People, Through Exclusive Agreement to Distribute Virax Biolabs' Mpox PCR Detection Kits

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

Sep 19, 2024, 3:40 PM EDT - 1 year ago

Cosmos Health Enters Development Phase for CCDL24, an Innovative Multitargeting Product for Gastrointestinal Disorders, with a Market Size Valued at Over $37.5 Billion

InfernoInv
InfernoInv Dec. 25 at 8:49 AM
$COSM Upside depends on translating ambition into measurable cadence, where each milestone now functions as a credibility checkpoint. Proof points carry more weight than guidance alone.
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 11:57 PM
$COSM This crooked CEO = dilution up the ass!
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 8:06 PM
$COSM With one trade this just shit the bed almost 6%. You people are in for a rude awakening Friday and next week when most baggies will be selling for next year's tax write off. I would be shocked if this isn't in the .30's by end of next week.
0 · Reply
BearTrapperA57
BearTrapperA57 Dec. 24 at 7:23 PM
$COSM he can buy all the shares he wants but he dilutes to do so
0 · Reply
Yatoxksy
Yatoxksy Dec. 24 at 7:17 PM
https://feeds.issuerdirect.com/news-release.html?newsid=8437669776005189&symbol=COSM Another paid promotional release focused on platform narrative and execution — while omitting material governance facts. Since 2022, shareholders have experienced severe dilution, with the share count expanding materially alongside executive compensation practices. Those facts are not addressed here. Claims and outcomes reconcile over time. Filings, facts, and results ultimately prevail. $COSM #ShareholderRights #Accountability #BoardAccountability
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 5:57 PM
$COSM Never getting your bags lifted.
0 · Reply
JohnTrack
JohnTrack Dec. 24 at 5:41 PM
$COSM still lurking, still watching...
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 5:07 PM
$COSM This crooked CEO has a Christmas gift for all you retail baggies/bulls ... and he doesn't believe in lube!
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 4:45 PM
$COSM This is ugly folks! The SEC or DOJ needs to shut this stock down and start arresting management ... beginning with the CEO!
0 · Reply
JohnTrack
JohnTrack Dec. 24 at 3:48 PM
$COSM news published some minutes ago https://www.rapidticker.com/news/cosm-cosmos-health-is-building-a-9d430b
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 3:19 PM
$COSM Once it goes red ... it's dead!
0 · Reply
DARKP00L
DARKP00L Dec. 24 at 2:38 PM
$COSM 09:07 on Dec. 24 2025 Cosmos Health Reports Its Vertically Integrated, Tariff-Resilient Platform Powers U.S. Expansion And Long-Term Growth; Surpassed $17M In Q3 Revenue #tradeideas
0 · Reply
Kid_Shelleen
Kid_Shelleen Dec. 24 at 2:22 PM
$COSM
0 · Reply
LONGTERM123
LONGTERM123 Dec. 24 at 2:15 PM
$COSM investors we do see COSM doing a 20/1 R/S next month.
0 · Reply
Love_To_Learn
Love_To_Learn Dec. 24 at 2:14 PM
$COSM ATTACHED SOMETHING TO THIS 0.55 FOR BELOVED
0 · Reply
kalvinl
kalvinl Dec. 24 at 2:05 PM
$COSM https://www.stocktitan.net/news/COSM/cosmos-health-is-building-a-platform-and-tariffs-are-accelerating-80fw02s4x003.html
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 1:19 PM
$COSM Look at the bright side folks, today you'll only be down half a day.
0 · Reply
JustB3liev3
JustB3liev3 Dec. 24 at 12:05 PM
$COSM fundamentals matter, but they dont. The algorithm is the way. Well beside Jesus! GOD IS GREAT. Sold $OCGN for some liquidity for Cosm for now. Also watching to see if we can actually get a follow through $ZOMDF
1 · Reply
Luvmepup
Luvmepup Dec. 24 at 11:49 AM
$COSM Folks, there's nothing complicated on what this crooked CEO is doing ... that is if you're willing to open your eyes of course!
0 · Reply
ThePixelTrader
ThePixelTrader Dec. 24 at 10:30 AM
$COSM Sentiment could pivot sharply depending on how resource allocation supports scalability without eroding optionality. Inconsistent delivery may prolong volatility.
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 9:18 AM
$COSM .45 bid ... day is already over!
0 · Reply
Luvmepup
Luvmepup Dec. 24 at 2:07 AM
$COSM @Akis1965 Cat got your tongue?
0 · Reply